The Impact and Management of Fibroids for Fertility. An Evidence-Based Approach

Obstetrics and Gynecology Clinics of North America

Volumn 39, Issue 4, 2012, Pages 521-533

  Guo, Xiaoxiao Catherine ^a   Segars, James H ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Assisted reproductive technology (ART); Hysteroscopy; Infertility; Leiomyoma; Magnetic resonance guided focused ultrasound (MRgFUS); Minimally invasive gynecologic surgeries; Myomectomy; Uterine artery embolization (UAE)

Indexed keywords

ASOPRISNIL; GESTAGEN; LETROZOLE; LEUPRORELIN; MIFEPRISTONE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PLACEBO; TRANEXAMIC ACID; ULIPRISTAL;

ABDOMINAL MYOMECTOMY; CELL PROLIFERATION; CESAREAN SECTION; DISEASE ASSOCIATION; ENDOCRINE DISEASE; ENDOMETRIAL DISEASE; ENDOMETRIAL THICKENING; ESTROGEN DEPRIVATION; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FETUS WASTAGE; HUMAN; HYSTEROSCOPY; INFERTILITY THERAPY; INTERMETHOD COMPARISON; LAPAROSCOPY; LONG TERM CARE; MAGNETIC RESONANCE GUIDED FOCUS ULTRASOUND; MALPRESENTATION; MYOMECTOMY; NUCLEAR MAGNETIC RESONANCE; PLACENTA PREVIA; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PREMATURE LABOR; PRIORITY JOURNAL; RECURRENT DISEASE; RETAINED PLACENTA; REVIEW; SIDE EFFECT; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; TUMOR LOCALIZATION; TUMOR VOLUME; UTERINE ARTERY EMBOLIZATION; UTERUS BLEEDING; UTERUS MYOMA;

EMBOLIZATION, THERAPEUTIC; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYSTEROSCOPY; INFERTILITY, FEMALE; LEIOMYOMA; MYOMETRIUM; PREGNANCY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; UTERINE MYOMECTOMY; UTERINE NEOPLASMS; UTERUS;

EID: 84870210338     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2012.09.005     Document Type: Review

References (60)

1. Walker C., Stewart E. Uterine fibroids: the elephant in the room. Science 2005, 308:1589-1592.
2. Cramer S., Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990, 94:435-438.
3. Day Baird D., Dunson D., Hill M., et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003, 188:100-107.
4. Ezzati M., Norian J., Segars J. Management of uterine fibroids in the patient pursuing assisted reproductive technologies. Womens Health (Lond Engl) 2009, 5:413-421.
5. Peddada S., Laughlin S., Miner K., et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A 2008, 105:19887-19892.
6. Cardozo E., Clark A., Banks N., et al. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol 2012, 206:211.e1-211.e9.
7. Cook H., Ezzati M., Segars J., et al. The impact of uterine leiomyomas on reproductive outcomes. Minerva Ginecol 2010, 62:225-236.
8. Donnez J., Jadoul P. What are the implications of myomas on fertility? A need for a debate?. Hum Reprod 2002, 17:1424-1430.
9. Rackow B., Taylor H. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril 2010, 93:2027-2034.
10. Sinclair D., Mastroyannis A., Taylor H. Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TFG-β3. J Clin Endocrinol Metab 2011, 96:412-421.
11. Bulletti C., De Ziegler D., Polli V., et al. The role of leiomyomas in infertility. J Am Assoc Gynecol Laparosc 1999, 6:441-445.
12. Pritts E., Parker W., Olive D. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009, 91:1215-1223.
13. Olive D., Pritts E. Fibroids and reproduction. Semin Reprod Med 2010, 28:218-227.
14. Somigliana E., Vercellini P., Daguati R., et al. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update 2007, 13:465-476.
15. Benecke C., Kruger T., Siebert T., et al. Effect of fibroids on fertility in patients undergoing assisted reproduction. A structured literature review. Gynecol Obstet Invest 2005, 59(4):225-230.
16. Pritts E. Fibroids and infertility: a systematic review of the evidence. Obstet Gynecol Surv 2001, 56:483-491.
17. Coronado G., Marshall L., Schwartz S. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol 2000, 95:764-769.
18. Qidwai G., Caughey A., Jacoby A. Obstetric outcomes in women with sonographically identified uterine leiomyomata. Obstet Gynecol 2006, 107:376-382.
19. Laughlin S., Baird D., Savitz D., et al. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol 2009, 113:630-635.
20. De Vivo A., Mancuso A., Giacobbe A., et al. Uterine myomas during pregnancy: a longitudinal sonographic study. Ultrasound Obstet Gynecol 2011, 37:361-365.
21. Stout M., Odibo A., Graseck A., et al. Leiomyomas at routine second trimester ultrasound examination and adverse obstetric outcomes. Obstet Gynecol 2010, 116:1056-1063.
22. Laughlin S., Hartmann K., Baird D. Postpartum factors and natural fibroid regression. Am J Obstet Gynecol 2011, 204:496.
23. Ouyang D.W., Economy K.E., Norwitz E.R. Obstetric complications of fibroids. Obstet Gynecol Clin North Am 2006, 33:153-169.
24. Exacoustòs C., Rosati P. Ultrasound diagnosis of uterine myomas and complications in pregnancy. Obstet Gynecol 1993, 82:97-101.
25. Johnson NL, Norwitz E, Segars JH. Management of fibroids in pregnancy. In: Fibroids: gynecology in practice. Oxford (United Kingdom): Wiley-Blackwell; in press.
26. Lee H., Norwitz E., Shaw J. Contemporary management of fibroids in pregnancy. Rev Obstet Gynecol 2010, 3:20-38.
27. Olive D., Lindheim S., Pritts E. Non-surgical management of leiomyoma: impact on fertility. Curr Opin Obstet Gynecol 2004, 16:239-243.
28. Stewart E. Uterine fibroids. Lancet 2001, 357:293-298.
29. Parsanezhad M., Azmoon M., Alborzi S., et al. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril 2010, 93:192-198.
30. Donnez J., Tomaszewski J., Vazquez F., et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 2012, 366:421-432.
31. Donnez J., Tatarchuk T., Bouchard P., et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 2012, 366:409-420.
32. Wilkens J., Chwalisz K., Han C., et al. Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy. J Clin Endocrinol Metab 2008, 93:4664-4671.
33. Williams A., Critchley H., Osei J., et al. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 month treatment in patients with symptomatic uterine leiomyomata. Hum Reprod 2007, 22:1696-1704.
34. Lasmar R., Xinmei Z., Indman P., et al. Feasibility of a new classification of submucous myomas: a multicenter study. Fertil Steril 2011, 95:2773-2777.
35. Goldberg J., Pereira L. Pregnancy outcomes following treatment for fibroids: uterine fibroid embolization versus laparoscopic myomectomy. Curr Opin Obstet Gynecol 2006, 18:402-406.
36. Casini M., Rossi F., Agostini R., et al. Effects of the position of fibroids on fertility. Gynecol Endocrinol 2006, 22:106-109.
37. Bulletti C., DE Ziegler D., Levi Setti P., et al. Myomas, pregnancy outcome, and in vitro fertilization. Ann N Y Acad Sci 2004, 1034:84-92.
38. Al Hilli M., Stewart E. Magnetic resonance-guided focused ultrasound surgery. Semin Reprod Med 2010, 28:242-249.
39. Vercellini P., Trespidi L., Zaina B., et al. Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial. Fertil Steril 2003, 79:1390-1395.
40. Rabinovici J., David M., Fukunishi H., et al. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril 2010, 93(1):199-209.
41. Ravina J., Herbreteau C., Ciracu-Vigneron N., et al. Arterial embolization to treat uterine myomata. Lancet 1995, 346:671-672.
42. Freed M., Spies J. Uterine artery embolization for fibroids: a review of current outcomes. Semin Reprod Med 2010, 28:235-241.
43. Spies J., Ascher S., Roth A., et al. Uterine artery embolization for leiomyomata. Obstet Gynecol 2001, 98:29-34.
44. Spies J., Roth A., Gonsalves S., et al. Ovarian function after uterine artery embolization for leiomyomata: assessment with use of serum follicle stimulating hormone assay. J Vasc Interv Radiol 2001, 12:437-442.
45. American College of Obstetricians and Gynecologists ACOG practice bulletin: alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol 2008, 112:387-400.
46. Pron G., Mocarski E., Bennett J., et al. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol 2005, 105:67-76.
47. Goldberg J., Pereira L., Berghella V. Pregnancy after uterine artery embolization. Obstet Gynecol 2002, 100(5):869-872.
48. Homer H., Sarodigan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril 2010, 92:324-330.
49. Mara M., Horak P., Kubinova K., et al. Hysteroscopy after uterine fibroid embolization: evaluation of intrauterine findings in 127 patients. J Obstet Gynaecol Res 2012, 38(5):823-831.
50. Moss J., Cooper K., Khaund A., et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG 2011, 118:936-944.
51. van der Kooij S., Hehenkamp W., Volkers N., et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. Am J Obstet Gynecol 2010, 203:105.e1-105.e13.
52. Mara M., Maskova J., Fucikova Z., et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008, 31:73-85.
53. Carpenter T., Walker W. Pregnancy following uterine artery embolization for symptomatic fibroids: a series of 26 completed pregnancies. BJOG 2005, 11:321-325.
54. Klatsky P., Tran N., Caughey A., et al. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol 2008, 198:357-366.
55. Vergani P., Locatelli A., Ghidini A., et al. Large uterine leiomyomas and risk of cesarean delivery. Obstet Gynecol 2007, 109:410-414.
56. Rice J., Kay H., Mahony B. The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol 1989, 160:1212-1216.
57. Parker W. Uterine myomas: management. Fertil Steril 2007, 88:255-271.
58. Esteve J., Acosta R., Pérez Y., et al. Treatment of uterine myoma with 5 or 10 mg mifepristone during 6 months, post-treatment evolution over 12 months: double-blind randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 2012, 161:202-208.
59. Levens E., Potlog-Nahari C., Armstrong A., et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstet Gynecol 2008, 111:1129-1136.
60. Chwalisz K., Larsen L., Mattia-Goldberg C., et al. A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata. Fertil Steril 2007, 87:1399-1412.